Category: General Biotechnology

Drug Patent Expirations for the Week of June 26, 2022

PRADAXA (dabigatran etexilate mesylate) Boehringer ingelheim Patent: 6,087,380 Expiration: Jun 28, 2022 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent …


Biotechblog